The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2026

Filed:

Dec. 22, 2025
Applicant:

Xiamen Lp Pharmaceutical Co., Ltd., Xiamen, CN;

Inventors:

Rongbin Ling, Xiamen, CN;

Liyuan Chen, Xiamen, CN;

Zhoue Gao, Xiamen, CN;

Avinash Singh, Xiamen, CN;

Haijian Zhu, Xiamen, CN;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/191 (2006.01); A61K 31/197 (2006.01); A61K 31/4045 (2006.01); A61K 31/4415 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/40 (2006.01); A61P 25/20 (2006.01);
U.S. Cl.
CPC ...
A61K 9/006 (2013.01); A61K 9/0056 (2013.01); A61K 31/191 (2013.01); A61K 31/197 (2013.01); A61K 31/4045 (2013.01); A61K 31/4415 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/20 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61K 47/40 (2013.01); A61P 25/20 (2018.01);
Abstract

The present invention provides an oral transmucosal film for delivering four active ingredients of melatonin, GABA (gamma-aminobutyric acid), vitamin B5, and vitamin B6 through the sublingual mucosa. The film is a tri-layer structure containing amorphous active ingredients, one or more solubilizers, one or more antioxidants, one or more form stabilizers, and one or more hydrophobic stabilizers to deliver the drug through a transmucosal route. Comparing with an oral tablet, the present oral transmucosal film provides better treatment for insomnia. The oral sublingual film is a tri-layer film; the upper layer comprises melatonin, the middle layer comprises GABA and vitamin B6, and the lower layer comprises vitamin B5. The combination of the four active ingredients in a tri-layer oral transmucosal film provides a better treatment for insomnia than other existing methods.


Find Patent Forward Citations

Loading…